Search CAHR Abstracts

EPIDEMIOLOGY AND PUBLIC HEALTH / ÉPIDÉMIOLOGIE ET SANTÉ PUBLIQUE
POSTER SESSIONS / PRÉSENTATIONS D’AFFICHES

INTERNATIONAL PREVENTION RESEARCH

[337P] DECLINING SEXUALLY TRANSMITTED DISEASE AND HIV PREVELANCES AMONG ANTENATAL CLINIC (ANC) ATTENDERS IN NAIROBI, KENYA, FROM 1992 – 2001
S Moses¹, EN Ngugi², A Costigan^1,2, C Kariuki², FA Plummer^1
1University of Manitoba, Winnipeg, Manitoba; ²University of Nairobi, Nairobi, Kenya

[338P] A RANDOMIZED, CONTROLLED TRIAL OF MALE CIRCUMCISION (MC) TO PREVENT HIV INFECTION IN KISUMU, KENYA
S Moses¹, RC Bailey², K Agot³, I Maclean¹, AR Ronald¹, JO Ndinya-Achola^4
1University of Manitoba, Winnipeg, Manitoba; ²University of Chicago at Illinois, Chicago, Illinois; ³Moi University, Eldoret, Kenya; ⁴University of Nairobi, Nairobi, Kenya

[339P] CANADIAN PARTICIPATION IN THE FIRST PHASE III TRIAL OF A PREVENTIVE HIV VACCINE (AIDSVAX® B/B) – RESULTS TO 24 MONTHS
K Logue^1,4, J Vincelette², RS Hogg³, RS Remis¹, B Willoughby⁵, K Linnen^1,4, JL Roy², N McLean³, V Popovic⁶, J Young^6
1University of Toronto, Toronto, Ontario; ²Centre hospitalier de l’Universite de Montreal, Montreal, Quebec; ³BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia; ⁴cascAIDS Research Inc, Toronto, Ontario; ⁵Virion Health, Vancouver, British Columbia; ⁶VaxGen Inc, Brisbane, California

[340P] BRIDGING THE GAP BETWEEN PHASE III VACCINE TRIALS AND VACCINE AVAILABILITY – A ROLE FOR MATHEMATICAL MODELS AND NEW STATISTICAL METHODS
K Desai¹, GP Garnett¹, M-C Boily², BR Masse^3
1Imperial College, London, United Kingdom; ²Centers for Disease Control, Atlanta, Georgia; ³SCHARP, Seattle, Washingon